Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Phenylpropanolamine hydrochloride
Cyton Biosciences Ltd
QG04BX91
Phenylpropanolamine hydrochloride
15 mg/tablet
Tablet
POM: Prescription Only Medicine as defined in relevant national legislation
Dogs
phenylpropanolamin
Hormone
Authorised
2018-03-23
Health Products Regulatory Authority 12 April 2018 CRN000TRT Page 1 of 6 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Proin 15 mg chewable tablets for dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE: Phenylpropanolamine Hydrochloride 15 mg (as phenylpropanolamine) 12.1 mg EXCIPIENTS: Dark Brown lake LB506 For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Chewable tablet Liver-flavoured, brown coloured, round, biconvex, un-coated tablets, with a break-line on one side and embossed with PROIN 15 on the other side. The tablets can be divided into halves. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the management of urinary incontinence associated with urethral sphincter incompetence in the bitch, particularly that associated with ovariohysterectomy. 4.3 CONTRAINDICATIONS Do not use in hypertensive animals or in animals that become hypertensive after initiating therapy. Do not administer to patients treated with non-selective monoamine oxidase inhibitors. Health Products Regulatory Authority 12 April 2018 CRN000TRT Page 2 of 6 Do not use in case of known hypersensitivity to active substance or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES In bitches less than 1 year old the possibility of anatomical disorders contributing to incontinence should be considered prior to treatment. Do not use the product for the treatment of behavioural causes of inappropriate urination. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Phenylpropanolamine, a sympathomimetic drug, may affect the cardiovascular system, especially blood pressure and heart rate, and should be used with caution in animals with cardiovascular diseases. Phenylpropanolamine has been shown to increase mean arterial blood pressure resulting in hypertension over time. Animals administered the product should therefore be monitored for signs of hypertension, particularly with prolonged use of the produ Read the complete document